Latest Research in Multiple Myeloma Research and Treatments
71 research papers · 2026 median publication year
Top Research Topics in Multiple Myeloma Research and Treatments
- Multiple Myeloma Research and Treatments — 50 papers
- CAR-T cell therapy research — 7 papers
- Dermatologic Treatments and Research — 2 papers
- Economic and Financial Impacts of Cancer — 1 papers
- Protein Degradation and Inhibitors — 1 papers
- Polyomavirus and related diseases — 1 papers
- Venous Thromboembolism Diagnosis and Management — 1 papers
- Hematopoietic Stem Cell Transplantation — 1 papers
- Bioactive Compounds and Antitumor Agents — 1 papers
- Chronic Lymphocytic Leukemia Research — 1 papers
Highest-Cited Papers
- Incidentally detected vertebral fractures and risk of myeloma: a prospective cohort study of 9059 CT-scanned Danish general population individuals
- Extracorporeal Free-Light-Chain Removal in Myeloma Cast Nephropathy: Plasma Exchange and Hemodialysis Strategies in the Era of Effective Antimyeloma Therapy
- Diagnostic and prognostic value of bone metabolism biomarkers in newly diagnosed plasma cell myeloma
- Impact of maintenance therapy on survival after autologous stem cell transplant for multiple myeloma regardless of response: a global analysis
- Are all risk factors created equal in multiple myeloma?
- Salvage Autologous Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma: Long-Term Efficacy and Safety Outcomes from a Single-Center Real-World Cohort
- Belantamab mafodotin plus venetoclax in t(11;14)-positive relapsed or refractory multiple myeloma – the BELI(E)VE trial
- T-cell dynamics, CD8/NK ratio and tumor survival hallmarks determine response to T-cell bispecific forimtamig in myeloma
- Toxicity‐Related Treatment Cessation in Newly Diagnosed Multiple Myeloma—Risk Factors and Survival: An Analysis From the APAC and ANZ Myeloma and Related Diseases Registry
- Cutaneous Toxicities of Anti‐ GPRC 5 D Bispecific Antibodies for Multiple Myeloma: Retrospective Study
- Early deep response to cilta-cel as 2nd CAR T-Cell therapy after CELMoD-based bridging for advanced multiple myeloma
- Outcomes in patients with multiple myeloma and renal impairment undergoing autologous hematopoietic cell transplantation
- REVEAL-MM: retrospective evaluation of variables in early assessment and landmark trends in multiple myeloma—a US claims-based case-control study
- 18F-FDG PET/CT in multiple myeloma: A brief review.
- Imaging B cell maturation antigen in multiple myeloma
- The Prognostic Significance of Dynamic Monitoring of Minimal Residual Disease Status in Patients with Multiple Myeloma: A Real-World Study
- Using WB-LDCT to differentiate between benign and malignant medullary lesions in the appendicular skeleton of patients with plasma cell diseases
- Resolving Therapeutic Monoclonal Antibody Interference in an Immunoglobulin M Kappa Multiple Myeloma Patient Using a Mass Spectrometry Assay
- Healthcare utilization patterns and systemic barriers to care among adult hematologic malignancy survivors
- Threshold Price of Belantamab for Relapsed/Refractory Multiple Myeloma in China: A Cost-Effectiveness Analysis